Visfatin-a proinflammatory adipokine-in gallstone disease

American Journal of Surgery

Volumn 199, Issue 4, 2010, Pages 459-465

  Wang, Shen Nien ^a,b   Yeh, Yao Tsung ^c   Wang, Sen Teh ^d   Chuang, Shih Chang ^b   Wang, Chao Ling ^e   Yu, Ming Lung ^e   Lee, King Teh ^b  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b Faculty of Medicine   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adipokine; Cholesterol; Gallstone; Obesity; Pigment; Visfatin

Indexed keywords

CHOLESTEROL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; BODY MASS; CHEMICAL COMPOSITION; CHOLECYSTECTOMY; CHOLELITHIASIS; CHOLESTEROL STONE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFRARED SPECTROSCOPY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOKINES; ADULT; AGED; BILE PIGMENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLELITHIASIS; CHOLESTEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; ODDS RATIO; RISK FACTORS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 77949912359     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.01.014     Document Type: Article

References (27)

1. Everhart J.E., Khare M., Hill M., et al. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 117 (1999) 632-639
2. Halldestam I., Enell E.L., Kullman E., et al. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg 91 (2004) 734-738
3. Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J 77 (2001) 221-229
4. Shaffer E.A. Gallstone disease: epidemiology of gallbladder stone disease. Best pract res clin Gastroenterol 20 (2006) 981-996
5. Donovan J.M. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am 28 (1999) 75-97
6. Hsing A.W., Sakoda L.C., and Chua Jr. S. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86 (2007) s843-s857
7. Yeh M.M., and Brunt E.M. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 128 (2007) 837-847
8. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004) 579-591
9. Tilg H., and Moschen A.R. Adipocytokines. Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006) 772-783
10. Samal B., Sun Y., Stearns G., et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14 (1994) 1431-1437
11. Fukuhara A., Matsuda M., Nishizawa M., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
12. McGlothlin J.R., Gao L., Lavoie T., et al. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 43 (2005) 127-141
13. Wang S.N., Yeh Y.T., Yu M.L., et al. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. Eur J Clin Invest 36 (2006) 176-180
14. Wang S.N., Yeh Y.T., Yu M.L., et al. Serum adiponectin levels in cholesterol and pigment cholelithiasis. Br J Surg 93 (2006) 981-986
15. Mantsch H.H., and Chapman D. Infrared Spectroscopy of Biomolecules (1996), John Wiley, New York
16. Kleiner O., Ramesh J., Huleihel M., et al. A comparative study of gallstones from children and adults using FTIR spectroscopy and fluorescence microscopy. BMC Gastroenterol 2 (2002) 3-16
17. Trotman B.W., and Soloway R.D. Pigment gallstone disease: summary of the National Institutes of Health -international workshop. J Hepatol 2 (1982) 879-884
18. Cetta F., Lombardo F., Giubbolini M., et al. Classification of gallstones and epidemiologic studies. Digest Dis Sci 40 (1995) 2189-2191
19. Choi K.M., Lee J.S., Kim E.J., et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 158 (2008) 203-207
20. Tilg H., and Moschen A.R. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond) 114 (2008) 275-288
21. Filippattos T.D., Derdemezis C.S., Kiortsis D.N., et al. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. J Endocrinol Invest 30 (2007) 323-326
22. Arner P. Visfatin-a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 91 (2006) 28-30
23. Haider D.G., Schindler K., Schaller G., et al. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91 (2006) 1578-1581
24. Jin H., Jiang B., Tang J., et al. Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res Clin Pract 79 (2008) 412-418
25. Ye S.Q., Somon B.A., Maloney J.P., et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 171 (2005) 361-370
26. Bajwa E.K., Yu C.L., Gong M.N., et al. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med 35 (2007) 1290-1295
27. Jia S.H., Li Y., Parodo J., et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113 (2004) 1318-1327